Estudo comparativo entre antlmoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias causadas por Leishmania (viannia) braziliensis

Estudo comparativo entre antlmoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias causadas por Leishmania (viannia) braziliensis

Show other versions (1)

Com o objetivo de comparar a eficácia, a tolerabilidade e a toxicidade do antimoniato de meglumina, do sulfato de aminosidine e do isotianato depentamidine no tratamento de lesões cutâneas primárias causadas por Leishmania (Viannia) braziliensis foi realizado um estudo de campo, aberto, randomizado,...

Full description

Bibliographic Details
Main Authors:	Dalmo Correia, Vanize O. Macêdo, Edgar M. Carvalho, Aldina Barrai, Albino V. Magalhães, Maria Virgínia A. de Abreu, Maria de La Glória Orge Orge, Philip Marsden
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 1996-10-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Tratamento da leishmaniose tegumentar americana Antimonial pentavalente Pentamidina Aminosidine Treatment of Tegumentary Leishmaniasis Pentavalent antimonials Pentamidine Aminosidine
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821996000500007

Similar Items

Estudo comparativo entre antlmoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias causadas por Leishmania (viannia) braziliensis
by: Dalmo Correia, et al.
Published: (1996-10-01)

Estudo terapêutico aberto com sulfato de aminosidine na leishmaniose mucosa causada for Leishmania (viannia) braziliensis
by: Gustavo A.S. Romero, et al.
Published: (1996-12-01)

Estudo terapêutico aberto com sulfato de aminosidine na leishmaniose mucosa causada for Leishmania (viannia) braziliensis
by: Gustavo A.S. Romero, et al.
Published: (1996-12-01)

Tratamento da leishmaniose mucosa com sulfato de aminosidine: resultados de dois anos de acompanhamento
by: Romero Gustavo A.S., et al.
Published: (1998-01-01)

Características físico-químicas do antimoniato de meglumina em diferentes condições de armazenamento
by: Gustavo Adolfo Sierra Romero, et al.
Published: (1996-10-01)

Eficácia do sulfato de aminosidine na leishmaniose visceral grave, resistente ao tratamento com antimonial pentavalente
by: Cleudson Castro, et al.
Published: (1995-09-01)

Eficácia do sulfato de aminosidine na leishmaniose visceral grave, resistente ao tratamento com antimonial pentavalente
by: Cleudson Castro, et al.
Published: (1995-09-01)

Parto prematuro após uso de antimonial pentavalente: relato de um caso Premature birth after the use of pentavalent antimonial: case report
by: Bruna Pinheiro Silveira, et al.
Published: (2003-07-01)

Características físico-químicas do antimoniato de meglumina em diferentes condições de armazenamento
by: Gustavo Adolfo Sierra Romero, et al.
Published: (1996-10-01)

Therapeutic trial in experimental tegumentary leishmaniasis caused by Leishmania (Leishmania) amazonensis. A comparative study between mefloquine and aminosidine Ensaio terapêutico na leishmaniose tegumentar experimental causada por Leishmania (Leishmania) amazonensis. Um estudo comparativo entre mefloquina e aminosidine
by: Letícia Oba Galvão, et al.
Published: (2000-08-01)

Avaliação da tolerância e nefrotoxicidade do antimonial pentavalente administrado na dose de 40mg Sb v/kg/dia, de 12/12h, por 30 dias na forma cutaneo-mucosa de leishmaniose
by: Raimunda N.R. Sampaio, et al.
Published: (1997-12-01)

COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

Óbito em caso de leishmaniose cutâneomucosa após o uso de antimonial pentavalente
by: Márcio Campos Oliveira, et al.
Published: (2005-05-01)

An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable Um esquema antimonial alternativo para ser empregado na leishmaniose cutânea quando altas doses de antimônio são indesejáveis
by: Manoel Paes de Oliveira-Neto, et al.
Published: (2006-08-01)

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
by: Weverson A. Ferreira, et al.
Published: (2014-04-01)

Um caso de leishmaniose cutâneo-mucosa tratado com sucesso com baixa dose de antimonial pentavalente
by: Valdir Sabbaga Amato, et al.
Published: (1998-04-01)

Estudo comparativo entre antimoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias por Leishmania (Viannia) braziliensis (L(V)b)
by: Dalmo Correia Filho
Published: (1994-09-01)

Glucantime resistant Leishmania promastigotes are sensitive to pentostam
by: Elizabeth Spangler Andrade Moreira, et al.
Published: (1992-12-01)

Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate
by: Deise Riba Coelho, et al.
Published: (2014-07-01)

O USO CLÍNICO DAS PENTAMIDINAS COM ESPECIAL REFERÊNCIA NAS LEISHMANIOSES
by: Jackson Maurício L. COSTA
Published: (1993-01-01)

High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls
by: Gustavo Adolfo Sierra Romero, et al.
Published: (2003-01-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
by: Valter Viana Andrade-Neto, et al.
Published: (2021-04-01)

Nueva metodología para la formulación de la vacuna Heberpenta-L
by: Imeray Díaz, et al.
Published: (2014-01-01)

Estudo comparativo da eficácia de isotionato de pentamidina administrada em três doses durante uma semana e de N-metil-glucamina 20mgSbV/kg/dia durante 20 dias para o tratamento da forma cutânea da leishmaniose tegumentar americana A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis
by: Carmen Déa Ribeiro de Paula, et al.
Published: (2003-06-01)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
by: Lucia Regina Brahim, et al.

Old world cutaneous leishmaniasis in Iran: clinical variants and treatments
by: Alireza Firooz, et al.
Published: (2021-10-01)

Visceral Leishmaniasis Treatment, Italy
by: Luigi Gradoni, et al.
Published: (2003-12-01)

Tratamento da Leishmaniose tegumentar americana, com lesão em mucosa, por meio do isotionato de pentamidina
by: Valdir Sabbaga Amato, et al.
Published: (1996-10-01)

Eficacia y toxicidad de los antimoniales pentavalentes (Glucantime y Pentostam) en un modelo animal de leishmaniasis cutánea americana: aplicación de la luminometría.
by: Hector Hernán Henao, et al.
Published: (2004-12-01)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
by: Saskia van Henten, et al.
Published: (2023-08-01)

Comparisso of intralesionally injected Zink sulfate and pentavalent Antimony compound in treatment of acute cutaneous leishmaniasis
by: A.R GHafarinejhad, et al.
Published: (2000-09-01)

Heat shock protein 70 (HSP70) expression in antimony susceptible/resistant clinical isolates of Leishmania donovani
by: Mahendra Maharjan, et al.
Published: (2015-12-01)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2019-03-01)

Estudo comparativo entre antimoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias por Leishmania (Viannia) braziliensis (L(V)b) A comparative study of meglumine antimoniate, pentamidine isothionate and aminosidine sulphate in the treatment of primary skin ulceration caused by Leishmania (Viannia) braziliensis (L(V)b)
by: Dalmo Correia Filho
Published: (1994-09-01)

Toxic response of antimony in the Comamonas testosteroni and its application in soil antimony bioremediation
by: Xiong Luo, et al.
Published: (2023-08-01)

A challenging case of cutaneous leishmaniasis with thrombophlebitic complication
by: Antoine Willemart, et al.
Published: (2023-12-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

High resolution melting analysis and detection of Leishmania resistance: the role of multi drug resistance 1 gene
by: Maryam Fekri Soofi Abadi, et al.
Published: (2021-08-01)